Cytopia Commences Phase II Cancer Drug Study

Armen Hareyan's picture
Advertisement

Cytopia has obtained regulatory approval to proceed with a Phase II clinical study assessing its lead anti-cancer drug in up to 24 multiple myeloma patients. Patient enrolment will soon commence.

Advertisement